Pacific Biosciences of California Inc
Change company Symbol lookup
Select an option...
PACB Pacific Biosciences of California Inc
OPCH Option Care Health Inc
OLFC Olfactory Biosciences Corp
OARFF Fort St James Nickel Corp
MDXG MiMedx Group Inc
CATY Cathay General Bancorp
ARAY Accuray Inc

Health Care : Life Sciences Tools & Services | Small Cap Blend
Company profile

Pacific Biosciences of California, Inc. designs, develops and manufactures sequencing systems to help scientists resolve genetically complex problems. The Company is engaged in the development, manufacturing and marketing of an integrated platform for genetic analysis. Its Single Molecule, Real-Time (SMRT) technology enables single molecule, real-time detection of biological processes. It offers The SMRT Cell, Phospholinked nucleotides and The PacBio RS II and Sequel instruments. Its SMRT technology enables the observation of deoxyribonucleic acid (DNA) synthesis as it occurs in real-time by harnessing the natural process of DNA replication, which is actuated by the DNA polymerase. Its phospholinked nucleotides have a fluorescent dye attached to the phosphate chain of the nucleotide rather than to the base. The PacBio RS II and Sequel instruments include optics, automated liquid handling, a touchscreen control interface and computational hardware and software.

Closing Price
Day's Change
0.34 (3.82%)
B/A Size
Day's High
Day's Low

10-day average volume:

Community Trust Bancorp, Inc. Declares Its Cash Dividend

4:00 pm ET July 29, 2020 (BusinessWire) Print

On July 28, 2020, the Board of Directors of Community Trust Bancorp, Inc. (NASDAQ: CTBI) declared a quarterly cash dividend of $0.385 per share beginning with the October 1, 2020 payment to shareholders of record on September 15, 2020. This represents an increase of 1.32% in the quarterly cash dividend. CTBI's increase in the cash dividend is less than previous increases as the Company recognizes the uncertainty of operating with the impact of COVID-19 on its customers and the US economy. With this uncertainty, CTBI made a substantial allocation to its allowance for credit losses during the first quarter of 2020 resulting in lower than expected earnings; however, CTBI experienced record earnings during the second quarter 2020. We are pleased to currently operate with all of our capital measures greatly exceeding those required to be considered well-capitalized by regulators. At June 30, 2020, we had a common equity Tier 1 capital ratio of 17.21% compared to a required 6.5%, a Tier 1 capital ratio of 18.93% versus the required 8.0%, a total capital ratio of 20.18% versus the required 10.0%, a Tier l leverage ratio of 12.92% versus the required 5.0%, and a capital conservation buffer of 12.18%. "We are pleased to have the ability to increase the cash dividend to our shareholders for the 40th consecutive year," said Jean R. Hale, Chairman, President and CEO.

Community Trust Bancorp, Inc., with assets of $5.0 billion, is headquartered in Pikeville, Kentucky and has 70 banking locations across eastern, northeastern, central, and south central Kentucky, six banking locations in southern West Virginia, three banking locations in northeastern Tennessee, four trust offices across Kentucky, and one trust office in Tennessee.

View source version on

SOURCE: Community Trust Bancorp, Inc.

Jean R. Hale, Chairman, President, and C.E.O., Community Trust Bancorp, Inc. at (606) 437-3294

comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.